Roche has nearly 200 potential drugs in development, a third of them based on new chemical compounds, said George Abercrombie, chief executive at Hoffmann-La Roche, the company’s U.S ...

The pivotal phase IIb ALIENTO study met the primary endpoint of a statistically significant reduction in the annualised exacerbation rate (AER) at 52 weeks when astegolimab was given every two weeksTh ...

Researchers at F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have synthesized benzimidazole derivatives acting as serine/threonine-protein kinase SIK2 (QIK) and/or SIK1 (SNF1LK) and/or SIK3 ...

PITTSBURGH — Generic drug maker Mylan has entered an agreement with Hoffmann La Roche concerning its version of an oral chemotherapy drug. Mylan announced Wednesday that it had entered a ...

F. Hoffmann-La Roche Ltd: Early data suggest Roche's NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A: ...

He noted that the redevelopment of the former Hoffmann-La Roche headquarters' 116-acre campus represents New Jersey’s largest redevelopment project.

NUTLEY — The New Jersey Economic Development Authority (EDA) has offered two big carrots to Ralph Lauren Corp. and Quest Diagnostics Inc. to move their operations to the former Hoffmann-La Roche ...

A-4522-03T3; Appellate Division; opinion by Wecker, J.A.D.; dissent by Wefing, P.J.A.D.; decided and approved for publication February 28, 2006. Before Judges Wefing ...